Board meeting held on April 12, 2025

Reported results are the point at which prior management commitments become checkable against audited or reviewed numbers.

• Margin trend against the prior period
• Cash from operations against reported profit
• Whether prior guidance is reaffirmed
• in the coming quarter, we don't expect any secondary sales. (management committed by Q2 FY27)
• we believe that we should be able to do fairly good in GSK China and Bonaire USA, coming quarter should be goo (management committed by Q1 FY27)